Company Filing History:
1 out of 832,812 Years Active: 2011
Title: Carlos A Del Carpio Munoz: Innovator in Synthetic Platelet Technology.
Introduction
Carlos A Del Carpio Munoz is a notable inventor based in Japan. He has made significant contributions to the field of synthetic biology, particularly in the development of synthetic platelet substitutes. His innovative work aims to enhance medical treatments related to blood clotting and platelet function.
Latest Patents
Carlos A Del Carpio Munoz holds a patent for a groundbreaking invention titled "Synthetic Platelets." This synthetic platelet substitute interacts with natural platelets and the (sub)endothelium. The invention comprises a carrier molecule made of lipidic particles with a cross-linked surface mesh. The lipidic particles include an inner lipidic particle formed from pharmaceutically acceptable particle-forming lipids. Additionally, hydrophilic polymer chains are linked to the surface of the lipidic particle, featuring crosslinkable end groups. The invention also includes at least one receptor molecule attached to the surface of the carrier molecule, which can be a peptide moiety specific for ligands involved in platelet function. Despite his innovative contributions, he currently holds 1 patents.
Career Highlights
Throughout his career, Carlos A Del Carpio Munoz has focused on advancing medical technologies. His work on synthetic platelets represents a significant step forward in the field of regenerative medicine. He has dedicated his research to improving patient outcomes through innovative solutions.
Collaborations
Carlos has collaborated with esteemed colleagues, including Maria Ic Gyongyossy-Issa and Jayachandran N Kizhakkedathu. These collaborations have further enriched his research and contributed to the development of his innovative technologies.
Conclusion
Carlos A Del Carpio Munoz is a pioneering inventor in the realm of synthetic platelet technology. His work has the potential to revolutionize treatments related to blood clotting and enhance patient care. His contributions to the field are noteworthy and reflect his commitment to innovation.